1 Here we describe a crow-sized stem bird, Falcatakely forstera
2 Here we describe a method for isolating human gut-associated
3 Here we describe a new series of LPA(1) agonists among which
4 Here we describe a platform for efficient Cas12a gene editing
5 Here we describe a platform for measuring arrestin recruitmen
6 Here we describe a platform for the detection of IgG anti-dru
7 Here we describe a reference-free workflow for diploid de nov
8 Here we describe a robust genetic program that intrinsically
9 Here we describe a second class of local excitatory inputs to
10 Here we describe a strategy utilizing pan-family viral assays
11 Here we describe a subset of thymus recirculating IL18R(+) Tr
12 Here we describe an analysis method that provides data-driven
13 Here we describe an ex vivo cultured human skin explant model
14 Here we describe an ultrasensitive form of polymerization-bas
15 Here we describe '
circularization for high-throughput analysi
16 Here we describe how unexpanded CGG repeats and their transla
17 Here we describe the development of a pan-RAS biologic inhibi
18 Here we describe the in vivo dynamics of hunger-promoting AgR
19 Here we describe the production of a range of mini-spidroins
20 Here we describe the use of discarded wound dressings as a no
21 Here, we describe a computational method HiNT (Hi-C for copy
22 Here, we describe a deficiency of cilia and flagella associat
23 Here, we describe a function for NEK10 in the regulation of p
24 Here, we describe a mechanism by which the innate immune syst
25 Here, we describe a methodology for targeted peptide quantifi
26 Here, we describe a morphogenetic movement in which the inter
27 Here, we describe a mouse model intended to reproduce heredit
28 Here, we describe a new fossil specimen from Drimolen Main Qu
29 Here, we describe a new resource, stdpopsim, that attempts to
30 Here, we describe a novel framework to address this challenge
31 Here, we describe a rare case of highly efficient near-cognat
32 Here, we describe a total synthesis of PvD(1), the defensin f
33 Here, we describe an approach to large-scale nuclear architec
34 Here, we describe an arrayed CRISPR screening method, Genome
35 Here, we describe an integrative structure determination appr
36 Here, we describe an optimization strategy for reducing scram
37 Here, we describe an optimized Cas9-AAV6-based genome editing
38 Here, we describe diseases known to be influenced by iCP acti
39 Here, we describe DNA enrichment of the zein gene from maize
40 Fragilariopsis cylindrus and Pseudo-nitzschia multistriata
Here, we describe how functional genomics and reverse genetic
41 Here, we describe how to use this method to label and/or gene
42 Here, we describe the characteristics of adults hospitalised
43 Here, we describe the crystal structures of two distinct isof
44 Here, we describe the development and use of an assay to moni
45 Here, we describe the development of dual-color (DC) tsMSQ to
46 Here, we describe the extent of resistance of E. dermatitidis
47 Here, we describe the synthesis and conformational analysis o
48 Here, we describe the two-phase process by which antigen driv
49 Here, we describe the UBPs developed by three research teams
50 Here, we described a new, comprehensive system of in silico m